首页> 外文期刊>ACS applied materials & interfaces >Preparation of Polymeric Prodrug Paclitaxel-Poly(lactic acid)-b-Polyisobutylene and Its Application in Coatings of a Drug Eluting Stent
【24h】

Preparation of Polymeric Prodrug Paclitaxel-Poly(lactic acid)-b-Polyisobutylene and Its Application in Coatings of a Drug Eluting Stent

机译:高分子前药紫杉醇-聚(乳酸)-b-聚异丁烯的制备及其在药物洗脱支架涂层中的应用

获取原文
获取原文并翻译 | 示例
       

摘要

To develop a novel biodegradable and quite adhesive coating material for fabricating a paclitaxel (PTX)-containing eluting stent, herein, we report two kinds of drug eluting stent (DES) materials. One of them is a prodrug, PTX end-capped poly(lactic acid)-b-polyisobutylene (PTX-PLA-b-PIB) diblock copolymer, which possesses favorable biodegradability and biocompatibility. The other is a mixture of PIB-b-PLA diblock copolymer and PTX. PIB-b-PLA was synthesized via the ring-opening polymerization (ROP) using hydroxyl-terminated polyisobutylene (PIB-OH) as the initiator, while the PTX-PLA-b-PIB prodrug was prepared through a combination of ROP and Cu(I)-catalyzed azide-alkyne cycloaddition "click" reaction. The chemical structures and compositions as well as the molecular weights and molecular weight distributions of these copolymers have been fully characterized by H-1 nuclear magnetic resonance, Fourier transform infrared, and gel permeation chromatography measurements. The thermal degradation behavior and glass transition temperature (Tg) of the copolymers were studied by thermogravimetric analysis and differential scanning calorimetry, respectively. The solutions of PTX-PLA-b-PIB and the PIB-b-PLA/PTX mixture were separately coated onto the bare metal stents to form the PTX-containing DES. Subsequently, the surface structures and morphologies of the bare stent and DES were studied by atomic force microscopy and scanning electron microscopy, respectively. The in vitro release of PTX from these stents was conducted in a buffer medium (PBS 7.4) at 37 degrees C. The results showed that the coating formed by a blend of PTX-PLA-b-PIB, PIB-b-PLA, and PTX yielded a release that was better sustained than those of the individual PTX-PLA-b-PIB prodrug or PIB-b-PLA/PTX mixture. MTT assays demonstrated that the stent coated with PTX-PLA-b-PIB displayed a cytotoxicity lower than that of the PIB-b-PLA/PTX mixed layer, and the biocompatibility of coatings can be effectively improved by the prodrug.
机译:为了开发用于制造含紫杉醇(PTX)的洗脱支架的新型可生物降解且非常粘的涂料,我们在此报告了两种药物洗脱支架(DES)材料。其中之一是前药,PTX封端的聚(乳酸)-b-聚异丁烯(PTX-PLA-b-PIB)二嵌段共聚物,具有良好的生物降解性和生物相容性。另一种是PIB-b-PLA二嵌段共聚物和PTX的混合物。 PIB-b-PLA是通过以羟基封端的聚异丁烯(PIB-OH)为引发剂的开环聚合(ROP)合成的,而PTX-PLA-b-PIB的前药是通过ROP和Cu( I)催化的叠氮化物-炔烃环加成“点击”反应。这些共聚物的化学结构和组成以及分子量和分子量分布已通过H-1核磁共振,傅立叶变换红外光谱和凝胶渗透色谱测量得到了充分表征。分别通过热重分析和差示扫描量热法研究了共聚物的热降解行为和玻璃化转变温度(Tg)。将PTX-PLA-b-PIB和PIB-b-PLA / PTX混合物的溶液分别涂覆在裸金属支架上,以形成含PTX的DES。随后,分别通过原子力显微镜和扫描电子显微镜研究了裸支架和DES的表面结构和形态。从这些支架中体外释放PTX是在37摄氏度的缓冲液(PBS 7.4)中进行的。结果表明,由PTX-PLA-b-PIB,PIB-b-PLA和PTX产生的释放比单个PTX-PLA-b-PIB前药或PIB-b-PLA / PTX混合物的释放更好。 MTT分析表明,涂有PTX-PLA-b-PIB的支架的细胞毒性低于PIB-b-PLA / PTX混合层,并且前药可以有效改善涂层的生物相容性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号